The Latest

Combination of Naltrexone and Bupropion May Help Treat Meth Use Disorder, Study Finds
Participants on the combination were almost six times more likely to have meth-negative urine samples after six weeks than those on the placebo. They also reported a slight reduction in cravings.

Self-Swabbing Is an Affirming and Effective Cervical-Cancer Screening Tool for Transmasculine People
Transmasculine people face an array of barriers when understanding their HPV risk and accessing cervical-cancer screenings.

These HIV Experts Engage Black and Brown Folks on the COVID-19 Vaccine Trials Despite Medical Mistrust
Trump’s “Operation Warp Speed” has left people of color even more wary about research, they say. But it’s still possible, if done the right way by the right people.

Holistic Care Pays Dividends in Managing HIV, Study Finds
It’s more than just HIV, but comprehensive care systems aren’t as available as they should be.

The COVID-19 Pandemic Is Turning More Doctors Into Social Media Influencers
These doctors have found strategies to address misinformation on the web by speaking directly to concerned audiences.

With In-Person Counseling Banned During the COVID-19 Pandemic, Telehealth Can Be a Lifeline
Psychotherapy, as a part of comprehensive HIV care, may forever be transformed.

Address Mental Health Issues During the COVID-19 Pandemic, Experts Advise
People who have survived the isolation of HIV now have a pandemic whose main intervention is isolation.

Why Do Researchers Think HIV Meds Might Work Against COVID-19?
At least one such drug still holds that promise against coronavirus, but in general there’s little precedent for the same drug blocking different viruses.

Has Deborah Birx Crossed the Line?
Widely respected by U.S. and African activists for her work on global AIDS, she’s also increasingly seen as playing fast and loose with COVID facts to appease President Trump.

America, Meet Tony Fauci. AIDS Activists Have Known Him a Long Time
Thirty years ago, the NIH legend deftly negotiated between bureaucrats and activists. As part of Trump’s COVID-19 team, can he negotiate between loyalty and truth?